Your session is about to expire
← Back to Search
UR-GOAL Communication Tool for Acute Myeloid Leukemia (UR-GOAL 2 Trial)
N/A
Recruiting
Led By Kah Poh Loh
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients who are English-speaking
Patients with newly diagnosed AML or being worked up for possible AML
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 1-4 weeks after treatment initiation
Awards & highlights
UR-GOAL 2 Trial Summary
This trial will test a new tool to help patients and their oncologists communicate better and make shared decisions.
Who is the study for?
This trial is for people aged 60 or older who have been newly diagnosed with Acute Myeloid Leukemia (AML) or are being evaluated for it. They must be able to make their own medical decisions and speak English. Caregivers can also join if they support the patient in health matters, are over 21, and speak English. Oncologists treating these patients can participate too.Check my eligibility
What is being tested?
The UR-GOAL tool is being tested against usual care to see if it improves how doctors and older AML patients talk about treatment options together. The study will involve 100 participants to check how well the tool works in real conversations.See study design
What are the potential side effects?
Since this trial focuses on a communication tool rather than a medication, there aren't typical drug side effects involved. However, discussing sensitive health information could potentially cause emotional discomfort.
UR-GOAL 2 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I speak English.
Select...
I have been recently diagnosed with AML or am being tested for it.
Select...
I am 60 years old or older.
UR-GOAL 2 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 1-4 weeks after treatment initiation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 1-4 weeks after treatment initiation
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Shared Decision Making
Secondary outcome measures
Patient-Centered Communication in Cancer Care (PCC-Ca-36)
UR-GOAL 2 Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: UR-GOALExperimental Treatment1 Intervention
UR-GOAL helps conducts assessments of fitness, elicits patient values via Best-Worst Scaling, and elicits preferences for prognostic information and assesses prognostic awareness. The tool also includes an AML educational video.
Group II: Usual careActive Control1 Intervention
Usual care
Find a Location
Who is running the clinical trial?
University of RochesterLead Sponsor
834 Previous Clinical Trials
518,192 Total Patients Enrolled
Kah Poh LohPrincipal InvestigatorUniversity of Rochester
5 Previous Clinical Trials
210 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I speak English.I am an English-speaking caregiver.I have chosen a caregiver or am eligible even without one.I have been recently diagnosed with AML or am being tested for it.I am an English-speaking oncologist.I can make my own health decisions, even if I have some memory problems.I am 60 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: UR-GOAL
- Group 2: Usual care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are applications being accepted for this trial at the present time?
"According to clinicaltrials.gov, this research effort is actively enrolling participants. It was initially made public on June 17th 2022 and the details were recently updated on the 21st of that month."
Answered by AI
How many enrollees are participating in this trial?
"Affirmative. Clinicaltrials.gov confirms the enrollment of patients in this medical research initiated on June 17th 2022 and updated four days later. The study seeks out 100 participants from a single site."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger